CPHI 2024: HTBA spotlights flavonoids’ science-backed health benefits
16 Oct 2024 | HTBA
On the showroom floor, we caught up with Tom D’Hoore, the chief commercial officer at HealthTech BioActives (HTBA), to discuss the science-backed benefits of the company’s flavonoid offerings for cardiovascular health and sports nutrition. Intervention studies showed improved arterial flexibility and reduced inflammation in the heart. D’Hoore points out that its flavonoids were shown to increase energy metabolism in amateur athletes. He also discusses current market trends and the importance of sustainability and consumer familiarity.
More videos
